Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of dihydromyricetin in preparing products for preventing or treating obesity

A technology for dihydromyricetin and obesity, which is applied in the field of nutrition to achieve the effects of no drug resistance, no toxic side effects, and significant preventive and therapeutic effects

Inactive Publication Date: 2019-07-26
SOUTH CHINA AGRI UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved by the present invention is to overcome the deficiencies in the application of existing dihydromyricetin and the defects of drugs for treating obesity, and provide a product that can prevent obesity and promote weight loss without any harm to the body, so as to prevent normal The body is obese, and the obesity of the body that cannot exercise normally and has obesity is treated, so as to prevent or treat various diseases caused by obesity, and also provide a new method for the prevention and treatment of obesity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of dihydromyricetin in preparing products for preventing or treating obesity
  • Application of dihydromyricetin in preparing products for preventing or treating obesity
  • Application of dihydromyricetin in preparing products for preventing or treating obesity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1 2

[0054] Example 1 Dihydromyricetin prevents weight gain in mice

[0055] 1. Experimental method

[0056] In order to explore the role of dihydromyricetin in preventing weight gain in mice, the mice from 4 to 12 weeks old were fed a high-fat diet every day; at the same time, the mice in the experimental group were fed with 200 mg / kg dihydromyricetin every morning, The mice in the control group were fed with an equal volume of PBS, and the mice in the experimental group and the control group were fed with no more than 200 μL each time. After continuous feeding for 8 weeks, the changes in the body weight of the mice were observed.

[0057] 2. Results

[0058] After feeding with dihydromyricetin and PBS respectively from the age of 4 weeks to the age of 12 weeks, the comparison chart of the changes in the body weight of the mice is shown in figure 1 As shown, the comparison chart of the feed intake of mice is shown in figure 2 As shown, it can be seen that on the basis of not i...

Embodiment 2

[0059] Embodiment 2 mouse nuclear magnetic resonance imaging

[0060] 1. Experimental method

[0061] The mice in the experimental group (fed with dihydromyricetin from the age of 4 weeks to 12 weeks) and the mice in the control group (fed with PBS from the age of 4 weeks to 12 weeks) were placed in the MRI apparatus respectively, Statistical determination of the respective muscle content and fat content ratio, the result analysis.

[0062] 2. Results

[0063] image 3 It is a comparison chart of muscle content and fat content of nuclear magnetic mice, Figure 4 It is a comparison chart of visceral fat, subcutaneous fat and liver tissue weight in mice, Figure 5 is a life-size comparison of visceral fat, subcutaneous fat, and liver tissue in mice, Figure 3-5 The results showed that dihydromyricetin can significantly reduce the muscle content of the body, reduce the size and fat content of various fat-related tissues, inhibit the fat accumulation induced by high-fat diet,...

Embodiment 3

[0064] Example 3 HE staining of mouse visceral fat, subcutaneous fat and liver tissue sections

[0065] (1) Paraffin sections are routinely dewaxed with xylene and ethanol to water;

[0066] (2) Hematoxylin staining for 10 minutes;

[0067] (3) Rinse with running water, remove residual color, differentiate in 0.7% hydrochloric acid ethanol for a few seconds, rinse with running water, the slices turn blue for about 15 minutes, and 95% ethanol for 30 seconds;

[0068] (4) Alcoholic eosin staining for 30 seconds;

[0069] (5) Rinse with distilled water for 30 seconds;

[0070] (6) I 95% ethanol for 30 seconds, II 95% ethanol for 30 seconds, I 100% ethanol for 30 seconds, II 100% ethanol for 30 seconds;

[0071] (7) Phenolic xylene for 30 seconds, (1:4 phenolic 1-xylene 4), I xylene for 30 seconds, II xylene for 30 seconds;

[0072] (8) Seal the slides with neutral gum and take pictures.

[0073] 2. Results

[0074] Image 6 It is the HE staining results of visceral fat, su...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of dihydromyricetin in preparing products for preventing or treating obesity. The application of the dihydromyricetin in preparing a medicament, food, a food additive or a health care product for preventing or treating the obesity is provided. The dihydromyricetin can be used for treatment of the obesity of the body unable to exercise normally, and can also be used for prevention of the normal body obesity. The invention further provides a pharmaceutical composition for preventing and / or treating the obesity. The pharmaceutical composition has a remarkable therapeutic effect, no side effects to the body and no drug resistance.

Description

technical field [0001] The invention belongs to the technical field of nutrition, and more specifically relates to the application of dihydromyricetin in the preparation of products for preventing or treating obesity. Background technique [0002] Obesity is defined as a disease by the American Medical Association in 2013 because excessive fat deposition in the body exceeds the normal medical state, which has negative implications for health. People usually determine whether they are obese by their body mass index (BMI), once the body mass index is 25 ~ 30kg / m 2 is defined as overweight. Obesity contributes to various diseases, especially cardiovascular disease, type 2 diabetes, obstructive sleep apnea, fatty liver, osteoarthritis and certain types of cancer. The most common causes of obesity are mainly the following three: excessive food intake, lack of physical exercise and genetic susceptibility; in addition, a few are caused by genes, endocrine disorders, drug treatmen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61P3/04A23L33/10
CPCA23V2002/00A61K31/352A23L33/10A61P3/04A23V2200/332A23V2250/2116
Inventor 王翀徐谷莉侯连杰蒋方毅黄波李华琴
Owner SOUTH CHINA AGRI UNIV